LBO — MCLEOD MEDICAL CENTER - DILLON
IRR: 16.9% | MOIC: 2.18x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.9%
IRR
2.18x
MOIC
$60.5M
Entry EV
$92.1M
Exit EV
$31.1M
Equity Invested
Sources & Uses
S&UTotal · $60.5M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $23.5M | 38.8% | |
| Sub Debt | $5.9M | 9.7% | |
| Equity | $31.1M | 51.5% | |
| Enterprise Value | $58.8M | 97.1% | |
| Transaction Fees | $1.8M | 2.9% | |
| Total Uses | $60.5M | 100.0% |
Interpretation
INTAt 2.18x MOIC and 16.9% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $8.8M |
| Exit Ev | $92.1M |
| Net Debt At Exit | $24.2M |
| Equity At Exit | $67.8M |
| Equity Invested | $31.1M |
| Total Value Created | $36.7M |
| Value From Growth | $30.4M |
| Value From Multiple | $2.9M |
| Value From Deleveraging | $5.2M |